premargin

Element List	Explanation
Introduction	Almujtama Alraida Medical Co. announces the results of its Ordinary General Assembly Meeting (first meeting), which was held via modern technology at 8:00 PM on Monday, Rajab 23, 1447 AH, corresponding to January 12, 2026 AD. The quorum for the meeting to be valid was met, in accordance with the company's bylaws.
City and Location of the General Assembly's Meeting	The company's main headquarters is in Jeddah, Al-Muhammadiyah district, through modern technological means.
Date of the General Assembly's Meeting	2026-01-12 Corresponding to 1447-07-23
Time of the General Assembly’s Meeting	20:00
Percentage of Attending Shareholders	64.44 %
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The following members of the Board of Directors attended the meeting: Mr. Omar Yousef Khojah (Chairman of the Board of Directors) Mr. Yousef Omar Khojah (Vice Chairman of the Board of Directors) Pharmacist/ Abdulaziz Omar Khojah (Member of the Board of Directors) Mr. Ahmed Abdel-Ilah Maghribi (Member of the Board of Directors) Mr. Karim Bachite (Member of the Board of Directors) Mr. Hamad Hamdan Al-Sourayia (Member of the Board of Directors)
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	The meeting was attended by the following committee heads: Mr. Awad Hamouda Al-Rubaie (Chairman of the Audit Committee) Mr. Ahmed Abdel-Ilah Maghribi (Chairman of the Nominations and Remuneration Committee) Mr. Rakan Mohammad Abunayyan (Chairman of the Strategy Committee)
Voting Results on the Items of the General Assembly's Meeting Agenda's	1. Approval of the Board of Directors’ resolution to appoint Mr. Hamad Hamdan Al-Sourayia as a member of the Board of Directors (independent), effective from his appointment date of 25/11/2025, to complete the Board’s term until the end of the current cycle on 31/07/2026, succeeding the former member Mr. Abdulaziz Ahmed Abdul Latif Bin Dayel (independent). 2. Approval of amending the Conflict of Interest Policy. 3. Approval of the Regulations and Criteria for Participating in Competing Businesses. 4. Approval of the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Shara’a District, with an annual value of (160,000) Riyals, excluding Value Added Tax (VAT) (15%), and a contract duration of (18) months starting from 07/03/2024. The value of transactions during the fiscal year 2024 amounted to (160,000) Riyals, excluding VAT (15%), along with a request to approve the renewal of the contract for 2025 for a period of one year until 06/09/2026. It is confirmed that all contract terms were agreed upon without granting any privileges or preferential conditions to any party. 5. Approval of the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Sanabel District, with an annual value of (550,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of ten years starting from 01/04/2023. The value of transactions during the fiscal year 2024 amounted to (550,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages. 6. Approval of the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Ruhaily District, with an annual value of (400,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of 9 years and 11 months starting from 01/05/2023. The value of transactions during the fiscal year 2024 amounted to (400,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages. 7. Approval of the transactions and contracts executed during 2024 that were concluded between the Company and Mr. Omar Yousuf Khojah, wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, has a direct interest, while an indirect interest exists for the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah. This pertains to a lease contract for a branch in Jeddah, Al-Marwah District, with an annual value of (420,000) Riyals, excluding Value Added Tax (VAT) (15%), for a period of ten years starting from 01/07/2024. The value of transactions during the fiscal year 2024 amounted to (210,000) Riyals, excluding VAT (15%), along with a request for authorization to continue the contract for the fiscal year 2025. It is noted that this contract was concluded without any preferential terms or advantages. 8. Approval of the transactions and contracts executed during 2024 that were concluded between the Company and Bright Screen Company (a single-person limited liability company owned by Mr. Mohammed Omar Khojah), wherein the Chairman of the Board of Directors, Mr. Omar Yousuf Khojah, the Vice Chairman of the Board of Directors, Mr. Yousuf Omar Khojah, and Board Member Pharmacist/ Abdulaziz Omar Khojah have an indirect interest. This pertains to a contract for the supply and installation of advertising screens for a total amount of (1,537,200) Riyals, excluding Value Added Tax (VAT) (15%). The value of transactions during the fiscal year 2024 amounted to (136,950) Riyals, excluding VAT (15%), along with a request for authorization to continue the supply for the fiscal year 2025. It is noted that this contract was concluded without preferential terms or advantages.

Almujtama Alraida Medical Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)